Dextran Sulfate Sodium Salt (MW 35000-45000): Gold-Standard Chemical Inducer for Experimental Colitis and Virology

Executive Summary: Dextran sulfate sodium salt (DSS; MW 35000-45000) is a polyanionic sulfated polysaccharide widely used to induce experimental colitis in murine models at concentrations of 2.5–5% (w/w), reliably mimicking acute and chronic ulcerative colitis pathology (Zhao et al., 2022). DSS acts by disrupting intestinal epithelial barrier function and promoting apoptosis of colonic epithelial cells (Mechanisms Article). It also inhibits HIV-1 replication by interfering with viral adsorption and entry (Expanding Horizons Article). DSS is highly water-soluble (≥55.5 mg/mL), supplied as a solid by APExBIO, and should be freshly prepared for each experiment (Product Page). This article details the biological rationale, mechanism, evidence, and practical guidance for DSS use in translational research.

Biological Rationale

Dextran sulfate sodium salt (DSS) is a chemically defined, polyanionic polymer derived from sulfated polymerized glucose. Its molecular weight (MW 35000-45000) ensures optimal solubility and biological activity for research applications (APExBIO). DSS is widely used to induce experimental colitis in mice, as it reliably elicits colonic epithelial apoptosis and barrier dysfunction, key features of human ulcerative colitis (Zhao et al., 2022). The DSS model facilitates study of inflammatory bowel disease (IBD) pathogenesis, immune regulation, and therapeutic interventions (Gold-Standard Article). Moreover, DSS is leveraged in virology, where its polyanionic nature inhibits HIV-1 replication at the adsorption and entry stages (Expanding Horizons Article).

Mechanism of Action of Dextran sulfate sodium salt (MW 35000-45000)

DSS induces epithelial cell apoptosis and disrupts the mucosal barrier by integrating into the colonic epithelium after oral administration in drinking water or feed (typically 2.5–5% w/w) (Mechanisms Article). This leads to increased mucosal permeability, exposure to luminal antigens, and activation of innate immune responses. Toll-Like receptor 4 (TLR4) and NOD-like receptor protein 3 (NLRP3) signaling are upregulated, driving the maturation of pro-inflammatory cytokines such as IL-1β and perpetuating inflammation (Zhao et al., 2022). DSS also acts as a competitive inhibitor of viral adsorption, specifically blocking HIV-1 entry to target cells without significant interference with blood coagulation (Expanding Horizons Article).

Evidence & Benchmarks

• DSS at 2.5–5% (w/w) in drinking water induces reproducible acute and chronic colitis in C57BL/6 mice, evidenced by weight loss, diarrhea, and histological mucosal damage (Zhao et al., 2022).
• DSS treatment triggers apoptosis and loss of colonic epithelial barrier integrity, increasing mucosal permeability and neutrophil infiltration (Mechanisms Article).
• DSS-induced colitis models exhibit upregulation of TLR4 and NLRP3 inflammasome pathways and increased IL-1β maturation (Zhao et al., 2022).
• Dextran sulfate sodium salt (MW 35000–45000) is water-soluble at ≥55.5 mg/mL and insoluble in ethanol or DMSO (APExBIO).
• DSS inhibits HIV-1 replication in vitro by blocking viral adsorption and entry, confirmed in multiple cell systems (Expanding Horizons Article).
• Long-term oral administration of DSS is not recommended for chronic studies due to potential off-target toxicity; solutions should be freshly prepared (APExBIO).

This article extends the detailed mechanistic focus of the Mechanisms Article by providing evidence-based guidance for workflow integration. It also updates the Gold-Standard Article by highlighting new applications in virology and compound screening.

Applications, Limits & Misconceptions

DSS (MW 35000-45000) is the reagent of choice for inducing experimental colitis in murine models, facilitating research into IBD mechanisms and anti-inflammatory drug development (Gold-Standard Article). It is also used to model acute and chronic intestinal inflammation, and in studies of host-pathogen interactions. In virology, DSS demonstrates potent inhibition of HIV-1 replication by targeting early steps of viral infection (Expanding Horizons Article). APExBIO supplies this compound as a solid for reliable, reproducible research workflows, with solubility and storage parameters optimized for laboratory use (APExBIO).

Common Pitfalls or Misconceptions

• DSS does not induce Crohn's disease-like pathology; it models ulcerative colitis specifically (Mechanisms Article).
• DSS-induced colitis is highly dependent on mouse strain, age, and microbiota composition; results may not be directly extrapolatable across models (Zhao et al., 2022).
• DSS is not suitable for use in ethanol or DMSO-based protocols due to insolubility (APExBIO).
• Freshly prepared DSS solutions are required; long-term storage of solutions leads to degradation (APExBIO).
• DSS does not directly affect adaptive immunity; its primary action is on epithelial barrier and innate immune signaling (Mechanisms Article).

Workflow Integration & Parameters

• Preparation: Dissolve DSS powder (MW 35000-45000) in sterile distilled water to a final concentration of 2.5–5% (w/w); verify complete dissolution (≥55.5 mg/mL solubility).
• Administration: Provide solution to mice ad libitum via drinking water for 5–7 days for acute colitis induction; adjust duration for chronic studies (Zhao et al., 2022).
• Controls: Include water-only negative controls and, if screening interventions, untreated and vehicle groups (Optimizing Models Article).
• Endpoints: Monitor weight loss, stool consistency, and histological scores; collect tissues for cytokine and gene expression analyses.
• Storage: Store DSS powder at room temperature; prepare fresh solutions prior to each experiment (APExBIO).

This article clarifies optimal DSS use parameters, extending the scenario-driven guidance of the Optimizing Models Article by providing precise solubility and administration details.

Conclusion & Outlook

Dextran sulfate sodium salt (MW 35000-45000) remains the gold-standard chemical inducer for murine experimental colitis, underpinning advances in ulcerative colitis research and anti-inflammatory drug discovery. Its defined mechanism of action and reproducible effects enable robust IBD modeling and translational studies. DSS also offers unique utility in virology, especially as a polyanionic inhibitor of HIV-1 replication. Researchers should adhere to recommended solubility, administration, and storage parameters to maximize reproducibility. For validated, high-purity DSS, the APExBIO B8205 kit provides consistent performance across applications.